CHU clermont-ferrand
Clermont-Ferrand, France
NCT Number: NCT05071157
The study aims to better understand the functioning of the heart of children and adolescents with anorexia nervosa or obesity, compared to the heart function of control subject. This project seeks to find out if a weight disorder affects the heart and whether a systematic cardiac assessment with appropriate management is then to be considered.
To meet this objective, several analyzes are planned including a speckle tracking echocardiography, allowing a non-invasive study of myocardial deformations.
The hypothesis is that two opposite weight disorders (anorexia nervosa and obesity) lead to similar complications: inflammation, fibrosis altering the myocardial structure and therefore its contractility. Both systolic and diastolic dysfunction appear. Investigator hypothesize that the determinants of this dysfunction involve part of the alteration of body mass, and partly qualitative alterations specific to each pathology.
Looking for future studies?
Notify Me12 year–18 year
Female
Observational
Clermont-Ferrand, France
The main objective is to evaluate the cardiac dysfunctions through the study of myocardial deformities in anorexic and obese adolescents, in comparison with controls. The choice of a pediatric population is explained by the probable precocity of the cardiac repercussions of these weight disorders. The desire to bring together in the same study two opposite weight disorders is because a certain number of complications are common to both: repercussions on the cardiac mass, presence of chronic systemic inflammation, and fibrosis. Comparison to normo-weighted healthy subjects will make it possible to determine whether certain alterations are directly attributable to body composition (in the case of a continuum of a parameter between the three groups) or, on the contrary, independent of body composition.
The search for the mechanisms at the origin of these alterations represents our secondary objective. For this, a correlation of the cardiac parameters with several factors such as: duration and severity of disorders, body composition, heart mass, presence of myocardial fibrosis, epicardial fat level, sympatho-vagal balance (by the cardiac variability), systemic inflammatory profile and potential pathways signaling involved (metabolomic analysis) will be carried out. All these parameters may impact cardiac function.
Adolescent girls participating in the study will benefit from a clinical examination with fat / lean body mass measurement by impedance, assessment of heart rate variability, blood test (inflammation marker, metabolomic analysis) and ultrasound heart. Thus, screening for heart disease, and more generally complications of their pathology, will be performed.
This project is important to answer the question of the necessity or not of a systematic cardiac assessment in these adolescents and the setting up of an adapted care
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at inclusion
echocardiographic parameter of myocardial deformation: index of myocardial systolic function in percent
Time frame: at inclusion during first night
holter measurement of standard deviation of all intervals between heart beat(SDNN) in ms
Time frame: at inclusion
fat mass and lean mass in percent
Time frame: at inclusion
blood sampling: N-Terminal-proBNP in ng/L
Time frame: at inclusion
blood sampling: CRP in mg/L
Time frame: at inclusion
blood sampling: oestradiol in pg/ml
Time frame: at inclusion
blood sampling: in g/L
Time frame: at inclusion
blood sampling: blood potassium in mmol/l
Time frame: at inclusion
electrocardiogram to determine ECG QT Interval
University Hospital, Clermont-Ferrand
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06784804
Anorexia Nervosa, Behavior
Eggenburg, Lower Austria, Austria
View Trial DetailsNCT00556036
Amenorrhea, Anorexia Nervosa
Boston, Massachusetts, United States
View Trial DetailsNCT00946816
Anorexia Nervosa, Body Weight
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT04127214
Anorexia Nervosa, Binge Eating
Argentona, Catalonia, Spain
View Trial Details